Latest from HelpDementia
Food Pocketing and Dementia Safety: Risks Families Should Address
Why pocketed food in dementia signals real aspiration risk, and the specific mealtime changes and screening steps that…
Questions to Ask About Familial Alzheimer’s Genetic Panel For Adults Over 65
Which Alzheimer's gene test actually fits your family history — and which one only matters if you're starting a…
Medicare-Linked Dementia Survey Data Priorities in 2026: Research Participation Questions for Adult Children
Adult children can't join this Medicare-linked dementia survey directly — eligibility runs entirely through a parent's…
LatAm-FINGERS Lifestyle Coaching Findings Across 11 Countries in 2026: What the Update Means for People With Mild Cognitive Impairment
A two-year, 11-country trial shows coached lifestyle programs beat self-guided ones by 55% on cognition — a checklist…
PrecivityAD2 as an Adjunct to a 2026 Alzheimer’s Assessment: How People With Mild Cognitive Impairment Can Compare Testing Options
A blood test can now stand in for a first look at amyloid pathology, ahead of a scan or spinal tap, for adults 40 and…
Familiar Music Sessions for Early-Stage Dementia: Setup, Supplies, and Safety
A personalized playlist, the right headphones, and a volume check matter more to a dementia music session than the…
HelpDementia.com has published practical, research-based articles on brain health and aging since 2019. Our editors cover Alzheimer’s disease, vascular dementia, Lewy body dementia, cognitive testing, medications, and family caregiving — informed by the National Institute on Aging, the Alzheimer’s Association, the CDC, and peer-reviewed research.
Explore Our Guides
Latest Articles
Food Pocketing and Dementia Safety: Risks Families Should Address
Why pocketed food in dementia signals real aspiration risk, and the specific mealtime changes and screening steps that address it.
Questions to Ask About Familial Alzheimer’s Genetic Panel For Adults Over 65
Which Alzheimer's gene test actually fits your family history — and which one only matters if you're starting a specific drug.
Medicare-Linked Dementia Survey Data Priorities in 2026: Research Participation Questions for Adult Children
Adult children can't join this Medicare-linked dementia survey directly — eligibility runs entirely through a parent's existing enrollment.
LatAm-FINGERS Lifestyle Coaching Findings Across 11 Countries in 2026: What the Update Means for People With Mild Cognitive Impairment
A two-year, 11-country trial shows coached lifestyle programs beat self-guided ones by 55% on cognition — a checklist for choosing one.
PrecivityAD2 as an Adjunct to a 2026 Alzheimer’s Assessment: How People With Mild Cognitive Impairment Can Compare Testing Options
A blood test can now stand in for a first look at amyloid pathology, ahead of a scan or spinal tap, for adults 40 and up.
Familiar Music Sessions for Early-Stage Dementia: Setup, Supplies, and Safety
A personalized playlist, the right headphones, and a volume check matter more to a dementia music session than the songs alone.
FDA’s 2026 At-Home Leqembi IQLIK Starting Dose: Access, Coverage, and Training Questions for People With Early Alzheimer’s
A caregiver's guide to the new at-home Leqembi starting dose — what training, testing, and insurance actually require before the first shot.
Home-Based Dementia Care Research Priorities in 2026: Questions Adult Children Can Ask Local Care Programs
A list of exact questions, tied to CMS's GUIDE Model and 2026 NIA research priorities, to bring to a dementia care program.
When Should Families Seek Medical Care for Food Pocketing in Dementia?
A caregiver's guide to the exact warning signs that separate a routine check-up from an urgent swallowing evaluation or emergency call.
Caregiver Guide to Wernicke-Korsakoff Syndrome and Dementia: Symptoms, Safety, and Daily Care
A stage-by-stage breakdown of Wernicke-Korsakoff syndrome, from the emergency signs of Wernicke's to the daily memory-support routines Korsakoff care requires.
How Doctors Use Familial Alzheimer’s Genetic Panel For Adults Over 65
ApoE genetic testing now decides amyloid-drug eligibility and monitoring intensity for patients over 65, not a diagnosis of Alzheimer's itself.
AAIC 2026 LatAm-FINGERS Cognitive Health Results: What the Update Means for People With Mild Cognitive Impairment
The trial enrolled people at elevated dementia risk, including many with measurable but mild cognitive decline, and tracked them for two years across 11...